First Interstate Bank Increases Stake in iShares Biotechnology ETF $IBB

First Interstate Bank lifted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 18.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,082 shares of the financial services provider’s stock after acquiring an additional 6,465 shares during the quarter. First Interstate Bank owned 0.09% of iShares Biotechnology ETF worth $6,937,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $201,000. AQR Capital Management LLC bought a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $455,000. Millennium Management LLC increased its holdings in iShares Biotechnology ETF by 140.8% during the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after buying an additional 143,893 shares during the period. M&T Bank Corp increased its holdings in iShares Biotechnology ETF by 39.3% during the second quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock valued at $337,000 after buying an additional 750 shares during the period. Finally, Walleye Capital LLC raised its stake in iShares Biotechnology ETF by 26.8% in the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after buying an additional 985 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.0%

Shares of NASDAQ:IBB opened at $196.34 on Thursday. iShares Biotechnology ETF has a 12-month low of $128.84 and a 12-month high of $198.71. The business’s fifty day simple moving average is $174.77 and its 200-day simple moving average is $172.48.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.